Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children—a randomized trial Paul A. Checchia, MD, FCCM, FACC, Ronald A. Bronicki, MD, Jared T. Muenzer, MD, David Dixon, PhD, Steve Raithel, BS, CCP, Sanjiv K. Gandhi, MD, Charles B. Huddleston, MD The Journal of Thoracic and Cardiovascular Surgery Volume 146, Issue 3, Pages 530-536 (September 2013) DOI: 10.1016/j.jtcvs.2012.09.100 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 A, Comparison of ventilator hours. B, Comparison of intensive care unit length of stay. P < .05 for both graphs. Solid bar, placebo group; hatched bar, gaseous nitric oxide group. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 530-536DOI: (10.1016/j.jtcvs.2012.09.100) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 A, Comparison of cardiac troponin values. P < .05 at all points. B, Comparison of B-type natriuretic peptide measurements. Solid line, placebo; hatched line, gaseous nitric oxide group. ∗P < .05 at 12- and 24-hour points. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 530-536DOI: (10.1016/j.jtcvs.2012.09.100) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions